CHU Montreal

Montreal, Quebec H2X 3E4

0 studies enrolling now · 2 studies all time

What they study most

Sickle Cell Disease

Studies at this site

• A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) — Running, not enrolling
• A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) — Running, not enrolling